Lucas Bruce 4
4 · Slide Insurance Holdings, Inc. · Filed May 4, 2026
Research Summary
AI-generated summary of this filing
Slide Insurance (SLDE) CEO Lucas Bruce Sells ~162K Shares
What Happened
Lucas Bruce, CEO of Slide Insurance (SLDE), had 22,918 restricted stock units convert to common shares (exercise/conversion, code M) on April 30, 2026. To cover taxes, 9,019 of those shares were withheld (code F) at $18.65 ($168,204). He then sold 85,436 shares in the open market on May 1, 2026 (avg ~$18.77, $1,603,634) and 67,205 shares on May 4, 2026 (avg ~$18.88, $1,268,830). Total shares sold (including tax withholding) were ~161,660 for total proceeds of approximately $3,040,668. The sales were made pursuant to a 10b5‑1 trading plan adopted November 21, 2025.
Key Details
- Transaction types: M = exercise/conversion of RSUs (22,918 shares acquired), F = tax withholding (9,019 shares), S = open market sales (85,436 and 67,205 shares).
- Dates & prices: April 30, 2026 (RSU vesting/conversion); May 1, 2026 sales ~ $18.77 avg; May 4, 2026 sales ~ $18.88 avg. Reported sale price range across transactions: ~$18.75–$19.06 per share.
- Proceeds: ~ $3,040,668 total from the reported dispositions.
- Shares owned after transaction: Not specified in the provided summary of the filing. The filing notes various holdings through trusts and spouse entities and contains disclaimers about beneficial ownership (see footnotes).
- Notable footnotes: sales were pursuant to a 10b5‑1 plan (F1); the converted securities were restricted stock units that vest monthly (F11, F12); several holdings are reported as held through trusts or entities with disclaimers of beneficial ownership (F3, F6, F8, F9, F10); tax withholding accounted for 9,019 shares (F5).
- Timeliness: Form 4 filed May 4, 2026 for transactions through May 4, 2026 — filing appears timely.
Context
These entries reflect RSU vesting (conversion to shares) followed by withholding of some shares to pay taxes and the sale of remaining shares under a prearranged 10b5‑1 plan. Exercise/conversion at $0.00 indicates RSUs converting to common stock rather than a cash option exercise. Sales under a 10b5‑1 plan are preplanned and routine; sales alone do not necessarily indicate the insider’s view of the company’s prospects. Purchases typically carry more informational weight for investors than routine sales.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-04-30+22,918→ 1,160,464 total - Tax Payment
Common Stock
2026-04-30$18.65/sh−9,019$168,204→ 1,151,445 total - Sale
Common Stock
[F1][F2][F3]2026-05-01$18.77/sh−85,436$1,603,634→ 36,485,568 total(indirect: By LLC) - Sale
Common Stock
[F1][F4][F3]2026-05-04$18.88/sh−67,205$1,268,830→ 36,418,363 total(indirect: By LLC) - Exercise/Conversion
Common Stock
[F5][F6]2026-04-30+22,918→ 222,000 total(indirect: By Spouse) - Exercise/Conversion
Restricted Stock Unit
[F11][F12]2026-04-30−22,918→ 185,307 total→ Common Stock (22,918 underlying) - Exercise/Conversion
Restricted Stock Unit
[F11][F12][F6]2026-04-30−22,918→ 185,307 total(indirect: By Spouse)→ Common Stock (22,918 underlying)
- 2,575,837(indirect: By Trust)
Common Stock
- 1,308,133(indirect: By Spouse)
Common Stock
[F7][F8] - 1,925,000(indirect: By Trust)
Common Stock
[F9] - 1,925,000(indirect: By Trust)
Common Stock
[F10]
Footnotes (12)
- [F1]Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.
- [F10]Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F11]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock
- [F12]These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.
- [F2]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.75 to $18.90 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F3]The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.80 to $19.06 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F5]The amount shown reflects the amount owned by the Reporting Person's spouse after the vesting of 22,918 restricted stock units on April 30, 2026 and the withholding of 9,019 shares of common stock for the payment of the tax liability associated therewith.
- [F6]Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F7]The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 15,097 shares of common stock between May 1-4, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.75 to $19.06 per share.
- [F8]Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F9]Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.